NMS · Biotechnology

FDMT (FDMT) Stock

$10.09 -0.88% NMS: FDMT Healthcare

Valuation

MetricValue
Price$10.09
Market Cap$527.47M
P/E Ratio-3.47
P/B Ratio0.87
P/S Ratio5.09
EPS (TTM)$-2.42
52-Week High$13.90
52-Week Low$3.68
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-27.67%
ROA-24.69%
ROCE-31.62%
Gross Margin-188.24%
Operating Margin-188.24%
Net Margin-1.82%
Debt/Equity0.05
Current Ratio9.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$18.0M$3.0M$21.0M$0$85.0M
Operating Profit$-71.0M$-110.0M$-113.0M$-188.0M$-160.0M
Net Profit$-71.0M$-107.0M$-101.0M$-161.0M$-140.0M
EPS$-2.46$-3.12$-2.58$-2.98$-2.42
Op Margin-395.5%-3516.5%-544.6%-507678.4%-187.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$353.0M$262.0M$340.0M$560.0M$567.0M
Total Liabilities$34.0M$31.0M$32.0M$50.0M$61.0M
Cash$153.0M$52.0M$249.0M$149.0M$60.0M
Borrowings$16.0M$16.0M$15.0M$25.0M$21.0M

Latest News

4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists GlobeNewswire · Jun 30, 2026 4D Molecular Therapeutics Completes Enrollment in Phase 3 Wet AMD Trial MT Newswires · Jun 29, 2026 4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD GlobeNewswire · Jun 29, 2026 4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital GlobeNewswire · Jun 29, 2026 Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker GlobeNewswire · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-69.0M$-87.0M$-76.0M$-135.0M$-109.0M
Investing Cash Flow$-182.0M$-29.0M$113.0M$-306.0M$-94.0M
Financing Cash Flow$4.0M$0$8.0M$6.0M$0
Net Cash Flow$-124.0M$-101.0M$197.0M$-100.0M$-89.0M
Free Cash Flow$-78.0M$-98.0M$-79.0M$-138.0M$-109.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-28.98%
Quick Ratio9.34
Interest Coverage—
Return 1Y120.38%
Return 3Y-43.19%
Return 5Y-49.81%

Ownership

Insiders Held3.32%
Institutions Held98.36%
Institutions Float Held101.74%
Institutional HolderSharesReport Date
Janus Henderson Group PLC5,247,1512026-03-31
RA Capital Management, L.P.5,049,7792026-03-31
Goldman Sachs Group Inc4,205,4382026-03-31
Blackrock Inc.4,145,3032026-03-31
Novo Holdings A/S3,650,7372026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADCTADC Therapeutics S.A. $1.19 +3.48% -1.09 $151.36M 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
CMPX $1.89 -4.55% -4.71 $340.37M 0.00%
GOSSGossamer Bio, Inc. $0.19 +38.24% -0.17 $44.10M 0.00%
KALV $27.00 +0.00% -8.28 $1.44B 0.00%

About FDMT

FDMT is led by CEO David H. Kirn, employs 227 people, headquartered in US, publicly traded since 2020.

FDMT stock trades at $10.09 with a market capitalization of $527.47M. The stock is valued at a price-to-earnings (P/E) ratio of -3.47, price-to-book of 0.87, price-to-sales of 5.09. Over the past 52 weeks the stock has ranged between $3.68 and $13.90, and currently trades 27.4% below its 52-week high.

On profitability, FDMT generates a return on equity (ROE) of -27.67%, return on capital employed of -31.62%, an operating margin of -188.24%, a net profit margin of -1.82%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides